Prognostic Value of Pentraxin-3 Level in Patients with STEMI
and Its Relationship with Heart Failure and Markers of
Oxidative Stress

J 2015

Prognostic Value of Pentraxin-3 Level in Patients with STEMI and Its Relationship with Heart Failure and Markers of Oxidative Stress

TOMANDLOVÁ, Marie, Jiří JARKOVSKÝ, Josef TOMANDL, Lenka KUBKOVA, Petr KALA et. al.

Basic information

Original name

Prognostic Value of Pentraxin-3 Level in Patients with STEMI and Its Relationship with Heart Failure and Markers of Oxidative Stress

Authors

TOMANDLOVÁ, Marie (203 Czech Republic, guarantor, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Josef TOMANDL (203 Czech Republic, belonging to the institution), Lenka KUBKOVA (203 Czech Republic), Petr KALA (203 Czech Republic, belonging to the institution), Simona LITTNEROVÁ (203 Czech Republic, belonging to the institution), Jana GOTTWALDOVÁ (203 Czech Republic, belonging to the institution), Petr KUBENA (203 Czech Republic, belonging to the institution), Eva GANOVSKÁ (703 Slovakia, belonging to the institution), Martin POLOCZEK (203 Czech Republic), Jindřich ŠPINAR (203 Czech Republic, belonging to the institution), Christian MUELLER (756 Switzerland), Alexandre MEBAZAA (250 France), Monika PÁVKOVÁ GOLDBERGOVÁ (203 Czech Republic, belonging to the institution) and Jiří PAŘENICA (203 Czech Republic, belonging to the institution)

Edition

Disease Markers, New York, Hindawi Publishing Corporation, 2015, 0278-0240

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.137

RIV identification code

RIV/00216224:14110/15:00083744

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1155/2015/159051

UT WoS

000353506800001

Keywords in English

ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; ACUTE CORONARY SYNDROME; PERFORMANCE LIQUID-CHROMATOGRAPHY; LONG PENTRAXIN; ANTIOXIDANT ACTIVITY; RISK-ASSESSMENT; TNF-ALPHA; ELEVATION; PTX3

Abstract

V originále

Objective. Pentraxin-3 (PTX3) appears to have a cardioprotective effect through a positive influence against postreperfusion damage. This study assesses the prognostic value of PTX3 level and its relationship with clinical parameters and markers of oxidative stress and nitric oxide metabolism in patients with ST-elevation myocardial infarction (STEMI). Methods. Plasma/serum levels of several biomarkers of inflammation and oxidative stress and nitrite/nitrate were assessed upon admission and 24 h after STEMI onset in patients treated by primary percutaneous coronary intervention. Results. ROC analysis showed that plasma PTX3 at 24 h was a strong predictor of 30-day and 1-year mortality and independent predictor of combined end-point of left ventricle dysfunction or mortality in 1 year. The inflammatory response expressed by PTX3 had a significant relationship with age, heart failure, infarct size, impaired flow in the infarct-related artery, and renal function and positively correlated with neopterin, TNF-alpha, 8-hydroxy-2'-deoxyguanosine, and nitrite/nitrate. Conclusions. Plasma PTX3 at 24 h after STEMI onset is a strong predictor of 30-day and 1-year mortality. PTX3 as a single biomarker is comparable with currently used scoring systems (TIMI or GRACE) or B-type natriuretic peptide. PTX3 is also an independent predictor of combined end-point of left ventricle dysfunction or mortality in 1 year.

Links

MUNI/A/0954/2013, interní kód MU

Name: Příspěvek chemických a biochemických metodik ke studiu molekulární podstaty vybraných patologických stavů a onemocnění (Acronym: BIOMET3)

Investor: Masaryk University, Category A

MUNI/A/1012/2013, interní kód MU

Name: Diagnostika akutní myokarditidy mimikující akutní infarkt myokardu s ST elevacemi

Investor: Masaryk University, Category A

Citovat

TOMANDLOVÁ, Marie, Jiří JARKOVSKÝ, Josef TOMANDL, Lenka KUBKOVA, Petr KALA, Simona LITTNEROVÁ, Jana GOTTWALDOVÁ, Petr KUBENA, Eva GANOVSKÁ, Martin POLOCZEK, Jindřich ŠPINAR, Christian MUELLER, Alexandre MEBAZAA, Monika PÁVKOVÁ GOLDBERGOVÁ and Jiří PAŘENICA. Prognostic Value of Pentraxin-3 Level in Patients with STEMI and Its Relationship with Heart Failure and Markers of Oxidative Stress. Disease Markers. New York: Hindawi Publishing Corporation, 2015, vol. 2015, No 159051, p. 1-11. ISSN 0278-0240. Available from: https://dx.doi.org/10.1155/2015/159051.

@article{1310363,
   author = {Tomandlová, Marie and Jarkovský, Jiří and Tomandl, Josef and Kubkova, Lenka and Kala, Petr and Littnerová, Simona and Gottwaldová, Jana and Kubena, Petr and Ganovská, Eva and Poloczek, Martin and Špinar, Jindřich and Mueller, Christian and Mebazaa, Alexandre and Pávková Goldbergová, Monika and Pařenica, Jiří},
   article_location = {New York},
   article_number = {159051},
   doi = {http://dx.doi.org/10.1155/2015/159051},
   keywords = {ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; ACUTE CORONARY SYNDROME; PERFORMANCE LIQUID-CHROMATOGRAPHY; LONG PENTRAXIN; ANTIOXIDANT ACTIVITY; RISK-ASSESSMENT; TNF-ALPHA; ELEVATION; PTX3},
   language = {eng},
   issn = {0278-0240},
   journal = {Disease Markers},
   title = {Prognostic Value of Pentraxin-3 Level in Patients with STEMI and Its Relationship with Heart Failure and Markers of Oxidative Stress},
   volume = {2015},
   year = {2015}
}

TY  - JOUR
ID  - 1310363
AU  - Tomandlová, Marie - Jarkovský, Jiří - Tomandl, Josef - Kubkova, Lenka - Kala, Petr - Littnerová, Simona - Gottwaldová, Jana - Kubena, Petr - Ganovská, Eva - Poloczek, Martin - Špinar, Jindřich - Mueller, Christian - Mebazaa, Alexandre - Pávková Goldbergová, Monika - Pařenica, Jiří
PY  - 2015
TI  - Prognostic Value of Pentraxin-3 Level in Patients with STEMI and Its Relationship with Heart Failure and Markers of Oxidative Stress
JF  - Disease Markers
VL  - 2015
IS  - 159051
SP  - 1-11
EP  - 1-11
PB  - Hindawi Publishing Corporation
SN  - 02780240
KW  - ACUTE MYOCARDIAL-INFARCTION
KW  - C-REACTIVE PROTEIN
KW  - ACUTE CORONARY SYNDROME
KW  - PERFORMANCE LIQUID-CHROMATOGRAPHY
KW  - LONG PENTRAXIN
KW  - ANTIOXIDANT ACTIVITY
KW  - RISK-ASSESSMENT
KW  - TNF-ALPHA
KW  - ELEVATION
KW  - PTX3
N2  - Objective. Pentraxin-3 (PTX3) appears to have a cardioprotective effect through a positive influence against postreperfusion damage. This study assesses the prognostic value of PTX3 level and its relationship with clinical parameters and markers of oxidative stress and nitric oxide metabolism in patients with ST-elevation myocardial infarction (STEMI). Methods. Plasma/serum levels of several biomarkers of inflammation and oxidative stress and nitrite/nitrate were assessed upon admission and 24 h after STEMI onset in patients treated by primary percutaneous coronary intervention. Results. ROC analysis showed that plasma PTX3 at 24 h was a strong predictor of 30-day and 1-year mortality and independent predictor of combined end-point of left ventricle dysfunction or mortality in 1 year. The inflammatory response expressed by PTX3 had a significant relationship with age, heart failure, infarct size, impaired flow in the infarct-related artery, and renal function and positively correlated with neopterin, TNF-alpha, 8-hydroxy-2'-deoxyguanosine, and nitrite/nitrate. Conclusions. Plasma PTX3 at 24 h after STEMI onset is a strong predictor of 30-day and 1-year mortality. PTX3 as a single biomarker is comparable with currently used scoring systems (TIMI or GRACE) or B-type natriuretic peptide. PTX3 is also an independent predictor of combined end-point of left ventricle dysfunction or mortality in 1 year.
ER  -

TOMANDLOVÁ, Marie, Jiří JARKOVSKÝ, Josef TOMANDL, Lenka KUBKOVA, Petr KALA, Simona LITTNEROVÁ, Jana GOTTWALDOVÁ, Petr KUBENA, Eva GANOVSKÁ, Martin POLOCZEK, Jindřich ŠPINAR, Christian MUELLER, Alexandre MEBAZAA, Monika PÁVKOVÁ GOLDBERGOVÁ and Jiří PAŘENICA. Prognostic Value of Pentraxin-3 Level in Patients with STEMI and Its Relationship with Heart Failure and Markers of Oxidative Stress. \textit{Disease Markers}. New York: Hindawi Publishing Corporation, 2015, vol.~2015, No~159051, p.~1-11. ISSN~0278-0240. Available from: https://dx.doi.org/10.1155/2015/159051.

Detailed Information on Publication Record